P
Pei-Hua Peng
Researcher at Memorial Hospital of South Bend
Publications - 5
Citations - 203
Pei-Hua Peng is an academic researcher from Memorial Hospital of South Bend. The author has contributed to research in topics: TFAM & genomic DNA. The author has an hindex of 3, co-authored 5 publications receiving 71 citations.
Papers
More filters
Journal ArticleDOI
N6-Deoxyadenosine Methylation in Mammalian Mitochondrial DNA
Ziyang Hao,Tong Wu,Xiaolong Cui,Pingping Zhu,Cai-Ping Tan,Xiaoyang Dou,Kai-Wen Hsu,Yueh-Te Lin,Pei-Hua Peng,Li-Sheng Zhang,Yawei Gao,Lulu Hu,Hui-Lung Sun,Allen C. Zhu,Jianzhao Liu,Kou-Juey Wu,Chuan He +16 more
TL;DR: It is reported that mammalian mitochondrial DNA (mtDNA) is enriched for 6mA, which is at least 1,300-fold higher than that in gDNA under normal growth conditions, corresponding to approximately four 6mA modifications on each mtDNA molecule.
Journal ArticleDOI
Hypoxia-induced lncRNA RP11-390F4.3 promotes epithelial-mesenchymal transition (EMT) and metastasis through upregulating EMT regulators.
TL;DR: It is demonstrated that LncRNA RP11-390F4.3 is induced by hypoxia/HIF-1α and is essential for Hypoxia-induced EMT and metastasis via the activation of multiple EMT regulators.
Journal Article
Liquid-liquid phase separation (LLPS) in cellular physiology and tumor biology.
TL;DR: The role of liquid-liquid phase separation (LLPS) in regulating normal cellular physiology and contributing to tumorigenesis is discussed in this paper, where the authors summarize the principle and components of LLPS, and describe how LLPS regulate these numerous biological processes and how disruption of the LLPS would cause disease formation.
Journal ArticleDOI
The role of hypoxia-induced long noncoding RNAs (lncRNAs) in tumorigenesis and metastasis.
TL;DR: The review aims to identify suitable lncRNAs that may provide feasible therapeutic venues for hypoxia-involved cancers and the role of a recently discovered lncRNA RP11-390F4.3 in hypoxIA-induced EMT is discussed.
Journal ArticleDOI
Chromatin accessibility analysis identifies GSTM1 as a prognostic marker in human glioblastoma patients.
Yin-Cheng Huang,Yin-Cheng Huang,Joseph Chieh-Yu Lai,Pei-Hua Peng,Kuo-Chen Wei,Kou-Juey Wu,Kou-Juey Wu,Kou-Juey Wu +7 more
TL;DR: In this paper, the authors used ATAC-seq and RNA-seq to identify GSTM1 (glutathione S-transferase mu-1) as a prognostic marker of GBM patient survival.